Literature DB >> 8764072

Proteasome complex as a potential cellular target of hepatitis B virus X protein.

J Huang1, J Kwong, E C Sun, T J Liang.   

Abstract

Although the biological importance of hepatitis B virus X protein (HBX) in the life cycle of hepatitis B virus has been well established, the cellular and molecular basis of its function remains largely undefined. Despite the association of multiple activities with HBX, none of them appear to provide a unifying hypothesis regarding the true biological function of HBX. Identification and characterization of cellular targets of HBX remain an essential goal in the elucidation of the molecular mechanisms of HBX. Using the Saccharomyces cerevisiae two-hybrid system, we have identified and characterized a novel subunit of the proteasome complex (XAPC7) that interacts specifically with HBX. We also showed that HBX binds specifically to XAPC7 in vitro. Mutagenesis studies have defined the domains of interaction to be critical for the function of HBX. Furthermore, overexpression of XAPC7 appeared to activate transcription by itself and antisense expression of XAPC7 was able to block transactivation by HBX. Therefore, the proteasome complex is possibly a functional target of HBX in cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764072      PMCID: PMC190518     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Selective protein degradation: a journey's end within the proteasome.

Authors:  S Jentsch; S Schlenker
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

Review 2.  From the cradle to the grave: ring complexes in the life of a protein.

Authors:  J S Weissman; P B Sigler; A L Horwich
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

Review 3.  Functions of the proteasome: the lysis at the end of the tunnel.

Authors:  A L Goldberg
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

4.  Significance of anti-HBx antibodies in hepatitis B virus infection.

Authors:  M Levrero; M Stemler; C Pasquinelli; A Alberti; O Jean-Jean; A Franco; C Balsano; D Diop; C Brechot; M Melegari
Journal:  Hepatology       Date:  1991-01       Impact factor: 17.425

5.  Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade.

Authors:  J Benn; R J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

6.  Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation.

Authors:  R Truant; J Antunovic; J Greenblatt; C Prives; J A Cromlish
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution.

Authors:  J Löwe; D Stock; B Jap; P Zwickl; W Baumeister; R Huber
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

8.  Hepatitis B virus transactivator protein X interacts with the TATA-binding protein.

Authors:  I Qadri; H F Maguire; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

9.  The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors.

Authors:  M Doria; N Klein; R Lucito; R J Schneider
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

10.  Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation.

Authors:  J H Cheong; M Yi; Y Lin; S Murakami
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

View more
  53 in total

Review 1.  Relationships between proteasomes and viral gene products.

Authors:  A S Jarrousse; K Gautier; S Apcher; S Badaoui; G Boissonnet; M H Dadet; L Henry; J P Bureau; H P Schmid; F Petit
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice.

Authors:  X Y Cao; J Liu; Z R Lian; M Clayton; J L Hu; M H Zhu; D M Fan; M Feitelson
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver.

Authors:  X Y Cao; J Liu; Z R Lian; M Clayton; J L Hu; M H Zhu; D M Fan; M Feitelson
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Microinjection technique used to study functional interaction between p53 and hepatitis B virus X gene in apoptosis.

Authors:  X W Wang
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

5.  C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification.

Authors:  M Krüger; C Beger; P J Welch; J R Barber; F Wong-Staal
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

6.  Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants.

Authors:  D Sitterlin; T H Lee; S Prigent; P Tiollais; J S Butel; C Transy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 7.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.

Authors:  N P Klein; R J Schneider
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

Review 9.  Regulatory mechanisms of viral hepatitis B and C.

Authors:  G Waris; A Siddiqui
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 10.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.